DEA

D-ERITADENINE

Find entries where: DEA

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	D-ERITADENINE
Identifiers	(2R,3R)-4-(6-aminopurin-9-yl)-2,3-dihydroxy-butanoic acid
Formula	C₉ H₁₁ N₅ O₄
Molecular Weight	253.215
Type	NON-POLYMER
Isomeric SMILES	c1nc(c2c(n1)n(cn2)C[C@H]([C@H](C(=O)O)O)O)N
InChI	InChI=1S/C9H11N5O4/c10-7-5-8(12-2-11-7)14(3-13-5)1-4(15)6(16)9(17)18/h2-4,6,15-16H,1H2,(H,17,18)(H2,10,11,12)/t4-,6-/m1/s1
InChIKey	LIEMBEWXEZJEEZ-INEUFUBQSA-N

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	2
Bond Count	30
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB03769
Name	D-Eritadenine
Groups	experimental
Synonyms	D-Eritadenine Eritadenine Lentinacin Lentysine
Categories	Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Purines
CAS number	23918-98-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Adenosylhomocysteinase	MSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARI...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682